RxDoctor Payments Data

Mohammad Shaar

Clinical Cardiac Electrophysiology · Dallas, TXNPI 1760915789

Payments from drug & device makers

What this record shows

This record is dominated by grants: $62,500 of the $87,480 with a category attached, or 71.4%. Abbott accounts for 67.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $45,300 and has fallen 95.6% since, to $1,996 in 2025.

$87,480in general payments, 2019–2025

Across 191 payments — averaging $458.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$59K
  • Medtronic$16K
  • Boston Scientific$6K
  • Philips North America LLC$6K
  • Biosense Webster, Inc.$356
  • Biotronik Inc.$227
  • plus $617 from 8 others

What the payments were for

  • Grants$62,50071%
  • Travel & lodging$16,21119%
  • Food & beverage$7,7609%
  • Education$1,0091%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$87,480 in reported general payments places this provider in the 80th percentile of 233 clinical cardiac electrophysiology providers in Texas.

See all clinical cardiac electrophysiology providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate16$127

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →